Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for VASCEPA
- Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Inflammatory Breast Cancer That Has Spread to Other Parts of the Body
- The Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk
- A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults
- An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19
- PRevention Using EPA Against coloREctal Cancer
- Pharmacodynamic Effects of a Free-Fatty Acid Formulation of Omega-3 Pentaenoic Acid in Adults With Hypertriglyceridemia
- PRevention Using EPA Against coloREctal Cancer
- Vascepa to Accelerate Lipoprotein Uptake and Elimination
- OMega-3 Fatty Acid for the Immune Modulation of Colorectal Cancer
- EPA for Metastasis Trial 2
- Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy
- Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®)
- Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)
- Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid
- Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects
- PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA
Clinical trials list
click for details